Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge

European Neuropsychopharmacology

Volumn 25, Issue 9, 2015, Pages 1421-1426

  Staal, Wouter G ^a,b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c Karakter   (Netherlands)

Author keywords

Autism; DRD3; Repetitive behavior; Review; Treatment

Indexed keywords

DOPAMINE 3 RECEPTOR; RISPERIDONE; DRD3 PROTEIN, HUMAN;

AGGRESSION; ARTICLE; AUTISM; BASAL GANGLION; CAUDATE NUCLEUS; COMPULSION; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; FRONTAL LOBE; GENETIC SCREENING; HEREDITY; HUMAN; IRRITABILITY; MENTAL DISEASE; NEUROIMAGING; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL INTERACTION; STEREOTYPY; AUTISM SPECTRUM DISORDER; DRUG EFFECTS; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTISM SPECTRUM DISORDER; BASAL GANGLIA; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D3; STEREOTYPED BEHAVIOR;

EID: 84941313582     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.08.011     Document Type: Article

References (37)

1. Shuvarikov A., Campbell I.M., Dittwald P., Neill N.J., Bialer M.G., Moore C., Wheeler P.G., Wallace S.E., Hannibal M.C., Murray M.F., Giovanni M.A., Terespolsky D., Sodhi S., Cassina M., Viskochil D., Moghaddam B., Herman K., Brown C.W., Beck C.R., Gambin A., Cheung S.W., Patel A., Lamb A.N., Shaffer L.G., Ellison J.W., Ravnan J.B., Stankiewicz P., Rosenfeld J.A. Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays. Hum. Mutat. 2013, 34(10):1415-1423. (Oct).
2. Wiśniowiecka-Kowalnik B., Kastory-Bronowska M., Bartnik M., Derwińska K., Dymczak-Domini W., Szumbarska D., Ziemka E., Szczałuba K., Sykulski M., Gambin T., Gambin A., Shaw C.A., Mazurczak T., Obersztyn E., Bocian E., Stankiewicz P. Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders. Eur. J. Hum. Genet. 2013, 21(6):620-625. (Jun).
3. Toma C., Hervás A., Balmaña N., Salgado M., Maristany M., Vilella E., Aguilera F., Orejuela C., Cuscó I., Gallastegui F., Pérez-Jurado L.A., Caballero-Andaluz R., Yd Diego-Otero, Guzmán-Alvarez G., Ramos-Quiroga J.A., Ribasés M., Bayés M., Cormand B. Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC. World J. Biol. Psychiatry 2013, 14(7):516-527. (Sep).
4. Staal W.G., de Krom M., de Jonge M.V. Brief report: the dopamine-3- receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD). J. Autism Dev. Disord. 2012, 42(5):885-888. (May).
5. de Krom M., Staal W.G., Ophoff R.A., Hendriks J., Buitelaar J., Franke B., et al. A common variant in DRD3 receptor is associated with autism spectrum disorder. Biol. Psychiatry 2009, 65(7):625-630.
6. Gassó P., Mas S., Bernardo M., Alvarez S., Parellada E., Lafuente A. A common variant in DRD3 gene is associated with risperidoneinduced extrapyramidal symptoms. Pharmacogen. J. 2009, 9(6):404-410. (Dec).
7. Wei J., Chu C., Wang Y., Yang Y., Wang Q., Li T., Zhang L., Ma X. Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict. Behav. 2012, 37(5):622-626. (May).
8. Joyce P.R., Rogers G.R., Miller A.L., Mulder R.T., Luty S.E., Kennedy M.A. Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry Res. 2003, 119(1-2):1-10. (Jul 15).
9. Light K.J., Joyce P.R., Luty S.E., Mulder R.T., Frampton C.M., Joyce L.R., Miller A.L., Kennedy M.A. Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive compulsive personality disorder in patients with major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(4):409-413. (Jun 5).
10. Taylor S. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol. Psychiatry 2013, 18(7):799-805. (Jul).
11. Billett E.A., Richter M.A., Sam F., Swinson R.P., Dai X.Y., King N., Badri F., Sasaki T., Buchanan J.A., Kennedy J.L. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr. Genet. 1998, 8(3):163-169. (Autumn).
12. Catalano M., Sciuto G., Di Bella D., Novelli E., Nobile M., Bellodi L. Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am. J. Med. Genet. 1994, 54(3):253-255. (Sep 15).
13. Díaz-Anzaldúa A., Joober R., Rivière J.B., Dion Y., Lespérance P., Richer F., Chouinard S., Rouleau G.A. Montreal Tourette Syndrome Study Group. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol. Psychiatry 2004, 9(3):272-277. (Mar).
14. Devor E.J., Dill-Devor R.M., Magee H.J. The Bal I and Msp I polymorphisms in the dopamine D3 receptor gene display, linkage disequilibrium with each other but no association with Tourette syndrome. Psychiatr. Genet. 1998, 8(2):49-52. (Summer).
15. Hebebrand J., Nöthen M.M., Lehmkuhl G., Poustka F., Schmidt M., Propping P., Remschmidt H. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene. German Tourette's Syndrome Collaborative Research Group. Lancet 1993, 341(8858):1483-1484. (Jun 5).
16. Brett P., Robertson M., Gurling H., Curtis D. Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette's syndrome. Lancet 1993, 341(8854):1225. (May 8).
17. Comings D.E., Muhleman D., Dietz G., Dino M., LeGro R., Gade R. Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet 1993, 341(8849):906. (Apr 3).
18. Agrawal A., Wetherill L., Bucholz K.K., Kramer J., Kuperman S., Lynskey M.T., Nurnberger J.I., Schuckit M., Tischfield J.A., Edenberg H.J., Foroud T., Bierut L.J. Genetic influences on craving for alcohol. Addict. Behav. 2013, 38(2):1501-1508. (Feb).
19. Bloch P.J., Nall A.H., Weller A.E., Ferraro T.N., Berrettini W.H., Kampman K.M., Pettinati H.M., Dackis C.A., O'Brien C.P., Oslin D.W., Lohoff F.W. Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence. Psychiatr. Genet. 2009, 19(5):275-276. (Oct).
20. Huang W., Payne T.J., Ma J.Z., Li M.D. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(7):1109-1115. (Oct 5).
21. Wiesbeck G.A., Dürsteler-MacFarland K.M., Wurst F.M., Walter M., Petitjean S., Müller S., Wodarz N., Böning J. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Addict. Biol. 2006, 11(1):72-75. (Mar).
22. Messas G., Meira-Lima I., Turchi M., Franco O., Guindalini C., Castelo A., Laranjeira R., Vallada H. Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. Psychiatr. Genet. 2005, 15(3):171-174. (Sep).
23. Lee M.S., Ryu S.H. No association between the dopamine D3 receptor gene and Korean alcohol dependence. Psychiatr. Genet. 2002, 12(3):173-176. (Sep); 12 (4) 237 (Erratum).
24. Li T., Liu X., Zhao J., Hu X., Ball D.M., Loh el-W, Sham P.C., Collier D.A. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am. J. Med. Genet. 2002, 114(3):329-335. (Apr8).
25. Comings D.E., Gonzalez N., Wu S., Saucier G., Johnson P., Verde R., MacMurray J.P. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol. Psychiatry 1999, 4(5):484-487. (Sep).
26. Kotler M., Cohen H., Kremer I., Mel H., Horowitz R., Ohel N., Gritsenko I., Nemanov L., Katz M., Ebstein R. No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction. Mol. Psychiatry 1999, 4(4):313-314. (Jul).
27. Thome J., Weijers H.G., Wiesbeck G.A., Sian J., Nara K., Böning J., Riederer P. Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatr. Genet. 1999, 9(1):17-21. (Mar).
28. Higuchi S., Muramatsu T., Matsushita S., Murayama M. No evidence of association between structural polymorphism at the dopamine D3 receptor locus and alcoholism in the Japanese. Am. J. Med. Genet. 1996, 67(4):412-414. (Jul 26).
29. Freimer M., Kranzler H., Satel S., Lacobelle J., Skipsey K., Charney D., Gelernter J. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict. Biol. 1996, 1(3):281-287.
30. Gurevich E.V., Joyce J.N. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 1999, 20(1):60-80. (Jan).
31. Nickl-Jockschat T., Habel U., Michel T.M., Manning J., Laird A.R., Fox P.T., Schneider F., Eickhoff S.B. Brain structure anomalies in autism spectrum disorder--a meta-analysis of VBM studies using anatomic likelihood estimation. Hum. Brain Mapp. 2012, 33(6):1470-1489. (Jun).
32. Di Martino A., Zuo X.N., Kelly C., Grzadzinski R., Mennes M., Schvarcz A., Rodman J., Lord C., Castellanos F.X., Milham M.P. Shared and distinct intrinsic functional network centrality in autism and attention-deficit/hyperactivity disorder. Biol. Psychiatry 2013, 74(8):623-632. (Oct 15).
33. Langen M., Bos D., Noordermeer S.D., Nederveen H., van Engeland H., Durston S. Changes in the development of striatum are involved in repetitive behavior in autism. Biol. Psychiatry 2013, (Sep 30).
34. Hua X., Thompson P.M., Leow A.D., Madsen S.K., Caplan R., Alger J.R., O'Neill J., Joshi K., Smalley S.L., Toga A.W., Levitt J.G. Brain growth rate abnormalities visualized in adolescents with autism. Hum. Brain Mapp. 2013, 34(2):425-436. (Feb).
35. Qiu A., Adler M., Crocetti D., Miller M.I., Mostofsky S.H. Basal ganglia shapes predict social, communication, and motor dysfunctions in boys with autism spectrum disorder. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49(6):539-551. (Jun), (551.e1-4).
36. Langen M., Durston S., Kas M.J., van Engeland H., Staal W.G. The neurobiology of repetitive behavior: And men. Neurosci. Biobehav. Rev. 2011, 35(3):356-365. (Jan).
37. Parikh M.S., Kolevzon A., Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J. Child Adolesc. Psychopharmacol. 2008, 18(2):157-178. (Apr).